NYXH: Nyxoah S.A Projected Price to Earnings

Brandmark of Nyxoah S.A. (NYXH)

Nyxoah S.A. (NYXH) is implementing advanced solutions to combat sleep apnea, creating long-term customer loyalty to its implants. Expansion in Europe is progressing rapidly, while entry into the US market remains limited by FDA reviews. This market valuation chart shows a coefficient of 0.00, confirming the status of the Belgian leader whose neurostimulators are becoming a full-fledged replacement for traditional masks.

NYXH - Nyxoah Market Cap to Projected Earnings over the range 07/04/2022 - 11/18/2026

Analytical breakdowns and data insights for company Nyxoah (NYXH)

- stock value and consensus price forecast:
Summary company analysis:NYXH Nyxoah, S.A.
Signature product of nyxoah.com

The forward P/E determines the fairness of the current market price relative to the business's expected future earnings. By analyzing the forward P/E of a company, an investor assesses the extent of the premium paid for future financial results. The metric is calculated by dividing the current market capitalization by the projected net income. For Nyxoah S.A. (NYXH), this indicator reflects the monetization potential of long-term implant maintenance. Lifetime control of stimulation systems creates a sustainable margin stream, fundamentally justifying the asset's investment attractiveness.

Direct competitors

Future Price to Earnings Intuitive Surgical Inc (ISRG)|DHR (Danaher Corp) - Future Price to Earnings Multiple|Forward P/E Multiple BDX (bd.com)|Market Cap to Projected Earnings steris.com (STE)|WST - Future Price to Earnings|BAX (Baxter International Inc.) - Price to Future Earnings Ratio|Masimo Corporation (MASI) - Future Price to Earnings|Price to Future Earnings Ratio STVN|Projected Price to Earnings TFX|Merit Medical (MMSI) - Market Cap to Projected Earnings|Projected Price to Earnings NVST (Envista Holdings)|Market Cap to Future Earnings Ratio ICUI|Future Price to Earnings Dentsply XRAY|Future Price to Earnings Multiple LMAT|ATRC: Projected Price to Earnings|STAA - Forward P/E Multiple|ChromaDex Corp (NAGE) - Future Price to Earnings|Projected Price to Earnings ZimVie|ANGO (angiodynamics.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Cerus Inc CERS|Future Price to Earnings Teknova (TKNO)|Monogram Orthopedics - Price to Future Earnings Ratio|Sharps Technology - Projected Price to Earnings|Market Cap to Future Earnings Ratio INFU (InfuSystem Holdings)|UTMD - Future Price to Earnings|Market Cap to Projected Earnings KORU Medical KRMD|microbotmedical.com (MBOT) - Future Price to Earnings|Price to Expected Earnings Ratio PDEX (pro-dex.com)|ZTEK (Zentek Corp) - Forward P/E Multiple|Future Price to Earnings ELUT|Future Price to Earnings Milestone Scientific Corp (MLSS)|NEXGEL, Inc - Price to Future Earnings Ratio|Forward P/E Multiple RVP (Retractable Technologies Inc.)|Harvard Bioscience, Inc. - Future Price to Earnings|FEMY - Future Price to Earnings|MHUA - Forward P/E Multiple|POAI: Forward P/E Multiple|Price to Future Earnings Ratio CJMB|Projected Price to Earnings ATRI|Projected Price to Earnings Ratio NeuroMetrix NURO